Comparative effectiveness of in-hospital use of recombinant factor VIIa for off-label indications vs. usual care
This report evaluates the level of evidence currently available to support the effectiveness and safety of using recombinant activated coagulation factor VII (rFVIIa) for clinical indications not approved by the U.S. Food and Drug Administration (FDA). rFVIIa is approved for a variety of uses in hem...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, MD
Agency for Healthcare Research and Quality
2010, [2010]
|
| Series: | Comparative effectiveness review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references